Position in ORGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$239,443
+$154,335 QoQ
Shares Held
98,537
+174.4% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 134 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 64%
None 36%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $802,494,373 across 36 Drug Manufacturers - Specialty & Generic names. ORGO ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
18,815,747 | $298,794,060 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
502,267 | $84,652,078 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
619,298 | $68,704,917 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
123,215 | $66,761,581 | |
| 5 | ZTS |
Zoetis Inc.
|
812,181 | $58,363,324 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,396,427 | $34,366,066 | |
| 7 | ALKS |
Alkermes plc.
|
630,325 | $33,029,029 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,581,869 | $27,382,151 |
All Filings in ORGO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $239,443 | 98,537 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $85,108 | 35,911 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $188,189 | 36,330 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $151,291 | 35,851 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $131,214 | 35,851 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $306,883 | 71,038 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $227,503 | 71,095 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $377,996 | 132,167 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $370,906 | 132,467 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,012,320 | 356,451 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,400,722 | 342,475 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,058,202 | 332,768 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,402,058 | 422,307 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,038,926 | 487,759 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $1,408,564 | 523,630 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,732,275 | 534,653 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,215,587 | 454,014 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,492,261 | 458,302 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,651,563 | 395,191 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,977,118 | 279,292 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,603,049 | 216,790 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||